XML 17 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Equity (Unaudited) - USD ($)
$ in Thousands
Total
Noncontrolling Interests
IDT Corp
Additional Paid-In Capital
IDT Corp
Treasury Stock
IDT Corp
Accumulated Other Comprehensive Loss
IDT Corp
Accumulated Deficit
IDT Corp
Class A Common Stock
IDT Corp
Class B Common Stock
Beginning Balance at Jul. 31, 2017 $ 154,557 $ 8,823 $ 394,462 $ (83,304) $ (2,343) $ (163,370) $ 33 $ 256
Dividends declared (9,440)         (9,440)    
Restricted Class B common stock purchased from employees (61)     (61)        
Transfer of right to receive equity to Howard S. Jonas (40) (40)            
Consolidation of Lipomedix Pharmaceuticals Ltd. 558 558            
Stock-based compensation 1,797   1,797          
Distributions to noncontrolling interests (717) (717)            
Other comprehensive loss/income (188)       (188)      
Net income (loss) (106) 470       (576)    
Ending Balance at Jan. 31, 2018 146,360 9,094 396,259 (83,365) (2,531) (173,386) 33 256
Beginning Balance at Oct. 31, 2017 148,050 8,739 395,272 (83,327) (2,741) (170,182) 33 256
Dividends declared (4,720)         (4,720)    
Restricted Class B common stock purchased from employees (38)     (38)        
Transfer of right to receive equity to Howard S. Jonas (40) (40)            
Consolidation of Lipomedix Pharmaceuticals Ltd. 558 558            
Stock-based compensation 987   987          
Distributions to noncontrolling interests (337) (337)            
Other comprehensive loss/income 210       210      
Net income (loss) 1,690 174       1,516    
Ending Balance at Jan. 31, 2018 146,360 9,094 396,259 (83,365) (2,531) (173,386) 33 256
Beginning Balance at Jul. 31, 2018 31,303 639 294,047 (85,597) (4,972) (173,103) 33 256
Adjustment from the adoption of change in revenue recognition (see Note 2)/in accounting for equity investments (see Note 8) | ASU 2014-09 9,857         9,857    
Adjustment from the adoption of change in revenue recognition (see Note 2)/in accounting for equity investments (see Note 8) | ASU 2016-01 1,173       33 1,140    
BALANCE at Jul. 31, 2018 42,333 639 294,047 (85,597) (4,939) (162,106) 33 256
Restricted Class B common stock purchased from employees (16)     (16)        
Repurchases of Class B common stock through repurchase program (3,854)     (3,854)        
Sale of Class B common stock to Howard S. Jonas 14,772   (22,968) 37,740        
Stock-based compensation 880   880          
Distributions to noncontrolling interests (737) (737)            
Other comprehensive loss/income 484       484      
Net income (loss) (659) 601       (1,260)    
Ending Balance at Jan. 31, 2019 53,203 503 271,959 (51,727) (4,455) (163,366) 33 256
Beginning Balance at Oct. 31, 2018 37,927 601 294,460 (89,451) (4,417) (163,555) 33 256
Restricted Class B common stock purchased from employees (16)     (16)        
Sale of Class B common stock to Howard S. Jonas 14,772   (22,968) 37,740        
Stock-based compensation 467   467          
Distributions to noncontrolling interests (398) (398)            
Other comprehensive loss/income (38)       (38)      
Net income (loss) 489 300       189    
Ending Balance at Jan. 31, 2019 $ 53,203 $ 503 $ 271,959 $ (51,727) $ (4,455) $ (163,366) $ 33 $ 256